135 related articles for article (PubMed ID: 32387835)
21. Somatic MAP2K1 Mutations Are Associated with Extracranial Arteriovenous Malformation.
Couto JA; Huang AY; Konczyk DJ; Goss JA; Fishman SJ; Mulliken JB; Warman ML; Greene AK
Am J Hum Genet; 2017 Mar; 100(3):546-554. PubMed ID: 28190454
[TBL] [Abstract][Full Text] [Related]
22. Fibroblasts from Patients with Melorheostosis Promote Angiogenesis in Healthy Endothelial Cells through Secreted Factors.
Hurley-Novatny AC; Allbritton-King JD; Jha S; Cowen EW; Colbert RA; Navid F; Bhattacharyya T
J Invest Dermatol; 2022 Sep; 142(9):2406-2414.e5. PubMed ID: 35189151
[TBL] [Abstract][Full Text] [Related]
23. Melorheostosis in a family with autosomal dominant osteopoikilosis.
Nevin NC; Thomas PS; Davis RI; Cowie GH
Am J Med Genet; 1999 Feb; 82(5):409-14. PubMed ID: 10069713
[TBL] [Abstract][Full Text] [Related]
24. Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis.
Hellemans J; Preobrazhenska O; Willaert A; Debeer P; Verdonk PC; Costa T; Janssens K; Menten B; Van Roy N; Vermeulen SJ; Savarirayan R; Van Hul W; Vanhoenacker F; Huylebroeck D; De Paepe A; Naeyaert JM; Vandesompele J; Speleman F; Verschueren K; Coucke PJ; Mortier GR
Nat Genet; 2004 Nov; 36(11):1213-8. PubMed ID: 15489854
[TBL] [Abstract][Full Text] [Related]
25. Constitutive activation of MEK1 in osteoprogenitors increases strength of bone despite impairing mineralization.
Fowlkes JL; Bunn RC; Ray PD; Kalaitzoglou E; Uppuganti S; Unal M; Nyman JS; Thrailkill KM
Bone; 2020 Jan; 130():115106. PubMed ID: 31689526
[TBL] [Abstract][Full Text] [Related]
26. Clinical Evaluation of Melorheostosis in the Context of a Natural History Clinical Study.
Jha S; Cowen EW; Lehky TJ; Alter K; Flynn L; Reynolds JC; Lange E; Katz JD; Marini JC; Siegel RM; Bhattacharyya T
JBMR Plus; 2019 Aug; 3(8):e10214. PubMed ID: 31485554
[TBL] [Abstract][Full Text] [Related]
27. [Identification of a de novo MAP2K1 gene variant in an affected patient with Cardio-facio-cutaneous syndrome].
Wang Q; Chen P; Peng Q; Liu J; Huang Y; Tang Z; Liu Y; Yuan H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 May; 37(5):567-569. PubMed ID: 32335888
[TBL] [Abstract][Full Text] [Related]
28. Cross-Sectional Imaging Useful in Melorheostosis.
Hurley-Novatny A; Karantanas AH; Papadakis GZ; Bhattacharyya T; Jha S
JBMR Plus; 2021 Apr; 5(4):e10472. PubMed ID: 33869990
[TBL] [Abstract][Full Text] [Related]
29. Melorheostosis: report of a new case with linear scleroderma.
Birtane M; Eryavuz M; Unalan H; Tüzün F
Clin Rheumatol; 1998; 17(6):543-5. PubMed ID: 9890690
[TBL] [Abstract][Full Text] [Related]
30. Novel Somatic Mutation in LEMD3 Splice Site Results in Buschke-Ollendorff Syndrome with Polyostotic Melorheostosis and Osteopoikilosis.
Gutierrez D; Cooper KD; Mitchell AL; Cohn HI
Pediatr Dermatol; 2015; 32(5):e219-20. PubMed ID: 26135202
[TBL] [Abstract][Full Text] [Related]
31. Endothelial MAP2K1 mutations in arteriovenous malformation activate the RAS/MAPK pathway.
Smits PJ; Konczyk DJ; Sudduth CL; Goss JA; Greene AK
Biochem Biophys Res Commun; 2020 Aug; 529(2):450-454. PubMed ID: 32703450
[TBL] [Abstract][Full Text] [Related]
32. [Melorheostosis of the hand. A case report].
von Gossler C; Kall S; Christopoulos G; Prommersberger KJ
Handchir Mikrochir Plast Chir; 2001 Sep; 33(5):328-31. PubMed ID: 11600949
[TBL] [Abstract][Full Text] [Related]
33. Melorheostosis: A Clinical, Pathologic, and Radiologic Case Series.
Fick CN; Fratzl-Zelman N; Roschger P; Klaushofer K; Jha S; Marini JC; Bhattacharyya T
Am J Surg Pathol; 2019 Nov; 43(11):1554-1559. PubMed ID: 31386640
[TBL] [Abstract][Full Text] [Related]
34. Three cases of melorheostosis with foot and ankle involvement.
Pino AE; Temple HT
Am J Orthop (Belle Mead NJ); 2012 Aug; 41(8):E115-9. PubMed ID: 22900256
[TBL] [Abstract][Full Text] [Related]
35. A TGF-beta-inducible cell adhesion molecule, betaig-h3, is downregulated in melorheostosis and involved in osteogenesis.
Kim JE; Kim EH; Han EH; Park RW; Park IH; Jun SH; Kim JC; Young MF; Kim IS
J Cell Biochem; 2000 Mar; 77(2):169-78. PubMed ID: 10723084
[TBL] [Abstract][Full Text] [Related]
36. Bone Features of Unaffected Skeletal Sites in Melorheostosis: A Case Report.
Indirli R; Messina C; Longhi M; Guabello G; Corbetta S
J Clin Densitom; 2020; 23(4):690-694. PubMed ID: 32057643
[TBL] [Abstract][Full Text] [Related]
37. Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations.
Scheffler M; Holzem A; Kron A; Nogova L; Ihle MA; von Levetzow C; Fassunke J; Wömpner C; Bitter E; Koleczko S; Abdulla DSY; Michels S; Fischer R; Riedel R; Weber JP; Westphal T; Gerigk U; Kern J; Kaminsky B; Randerath W; Kambartel KO; Merkelbach-Bruse S; Büttner R; Wolf J
Lung Cancer; 2020 Jun; 144():40-48. PubMed ID: 32361034
[TBL] [Abstract][Full Text] [Related]
38. Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.
Ye F; Gao H; Xiao L; Zuo Z; Liu Y; Zhao Q; Chen H; Feng W; Fu B; Sun L; Jiang X; He D; Jiang H; Yang M; Li L; Chen F; Liu X; Li S; Li Z; Jiang Y; Cheng L; Bu H
Int J Cancer; 2019 Mar; 144(6):1321-1330. PubMed ID: 30132833
[TBL] [Abstract][Full Text] [Related]
39. Arteriovenous malformation Map2k1 mutation affects vasculogenesis.
Sudduth CL; Smits PJ; Vivero MP; Cheng YS; Ad M; Konczyk DJ; Bischoff J; Warman ML; Greene AK
Sci Rep; 2023 Jul; 13(1):11074. PubMed ID: 37422456
[TBL] [Abstract][Full Text] [Related]
40. [Clinical analysis of a child with cardio-facio-cutaneous syndrome due to a de novo variant of MAP2K1 gene].
Cao H; Tong G; Huang R; Zhou T; Zhang W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Oct; 39(10):1129-1134. PubMed ID: 36184098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
